NAV
$123.32
AUM
$156.5M
Expense Ratio
-
Dividend Yield
0.00%
Beta
1.42
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +7.21% | +18.58% | +31.53% | +53.67% | +9.41% | +3.34% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Co | 11.94% |
| 2 | JNJ | Johnson & Johnson | 7.40% |
| 3 | ABBV | AbbVie Inc | 5.25% |
| 4 | UNH | UnitedHealth Group Inc | 4.70% |
| 5 | MRK | Merck & Co Inc | 4.02% |
| 6 | TMO | Thermo Fisher Scientific Inc | 2.52% |
| 7 | AMGN | Amgen Inc | 2.47% |
| 8 | GILD | Gilead Sciences Inc | 2.27% |
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and health care technology. It is non-diversified.
Inception Date: 2011-06-15